| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |